← Back to patent-cliff list
Sodium tungstate (Oxolife)
Tier C — Watch / tradeSodium tungstate (Oxolife)
OXOLIFE
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：Updating
Indications (approved)：Infertility, 女性不孕
Regional status
US
-
EU
Phase II
2021-09-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Sodium tungstate (Oxolife)?
Approved indications include: Infertility, 女性不孕.
When does the Sodium tungstate (Oxolife) patent expire?
No public expiry year is available for Sodium tungstate (Oxolife) yet; this page updates once verified.
How do I get a quote for Sodium tungstate (Oxolife) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21